Cyclacel Pharma (CYCC) Misses Q4 EPS by 33c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Net loss applicable to common shareholders: -3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.33).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Quantum eMotion receives U.S. patent notice for SecureKey technology
- UBS Reiterates Neutral Rating on ConAgra (CAG) as Sentiment Remains Mixed
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
